Being able to access high-quality healthcare at the times you need it most is vital. Regardless of whether this is a simple check-up, a medical review or
complex surgery, having a suitable healthcare package designed according to your medical needs will be beneficial in the long run.
The NHS has recently come under significant strain. Factors such as an increase in the number of patients, reduced funding and increased life expectancy have led to
long waiting times and limited treatments.
As a result, more individuals are now seeking private healthcare which, while it may be more expensive, offers faster and more effective treatment. Here we'll discuss
some of the main benefits of private healthcare and why it is becoming the ideal choice for healthcare in 2023.
Reduced waiting times
One of the main issues faced by the NHS is waiting times, with some patients being made to wait up to a year for routine hospital care. Currently, ambulance services
and A&E units are under unprecedented pressure and it is estimated that hundreds of deaths each week are associated with admission delays.
Understaffing has been a chronic issue in recent years in the NHS and is a major threat to the welfare of patients. This has been one of the major concerns that has
led to nurses and ambulance staff taking strike action. As nurses and hospital workers are put under higher strain, they are more likely to make mistakes, which
could well lead to patients coming into harm and making a claim.
Opting for private healthcare guarantees that you are able to access your appointments, surgeries and treatments much quicker, with some flexibility offered to align
with your lifestyle. The capacity to bypass the painfully long waiting times ensures you receive the necessary medical attention much sooner and could prevent the
emergence of other health complications.
The Pharmacists' Defence Association (PDA) has reacted to the chief pharmaceutical officer (CPhO) for Wales's offer for community pharmacy contractors,
offering a funding uplift for community pharmacy on the condition of an increase in pay for some staff by at least the amount currently being imposed upon NHS
employees.
The PDA has expressed a mixed reaction to the intervention being attempted by the Welsh government.
"It is unusual for a government to be so closely involved in the pay of their suppliers' employees and those at some community pharmacy employers have a contractual
right to a pay review at times of year that may not synchronize with the government's financial cycle, so this initiative may have different impacts at different
employers," said the association.
"In addition, the PDA negotiates pay at the largest two community pharmacy employers and works alongside other trade unions that organise other pharmacy workers.
This government intervention must not disrupt or attempt to bypass those processes."
In a recent report released by the Company Chemists' Association (CCA), data from the NHS Pharmacy First service indicates a substantial uptake and
positive impact on patient care just two months after its launch.
The CCA's findings shed light on the service's efficacy in meeting patient needs and its potential to alleviate pressure on General Practices (GPs) within the NHS.
According to the report, over 90,000 Pharmacy First consultations were conducted solely by CCA members within the initial two-month period.
Impressively, 88 per cent of these consultations, totaling 81,627, were deemed eligible for NHS-funded care indicating a significant demand for the service among
patients.
In the first month, the data revealed that more than 90 per cent of eligible patients received necessary care directly through Pharmacy First, bypassing the
need for further referral.